Microbiome Technologies

Microbiome Technologies is a Japanese biotechnology company specializing in the development and application of humanized microbiota mice for drug discovery and microbiome research. The company leverages proprietary technology to transplant human intestinal microflora into germ-free mice, creating highly accurate models for studying the interaction between the human microbiome and various diseases. Their services include comprehensive microbiome analysis, efficacy testing for live biotherapeutic products (LBPs), and the identification of specific bacterial strains with therapeutic potential. By providing a bridge between basic research and clinical application, Microbiome Technologies supports the development of novel treatments for inflammatory, metabolic, and immune-related conditions. The company operates as a venture originating from Keio University and the Central Institute for Experimental Animals.